Association Between Prebiotic or Probiotic Consumption and Risk of Type 2 Diabetes Mellitus in the General Adult Population

Yıl 2024, Cilt: 6 Sayı: 2, 141 - 148, 03.08.2024

Cansu Koşar Şahin Hatice Ceylan Şefika Tuğba Yangöz

https://doi.org/10.48071/sbuhemsirelik.1430172

Öz

Introduction: Decrease in microbiota diversity increases risk of diabetes by increasing harmful metabolites and activating
insulin resistance pathways. Adequate prebiotic and probiotic food consumption may be a potential tool in order to prevent
type 2 diabetes.
Aim: The aim of the research was to examine at the relationship between probiotic and prebiotic consumption and the risk of type 2 diabetes.
Method: A cross-sectional research design was used in this study. Data was obtained from December 2021 and June
2022 using Personal Information Form, Assessment of Probiotic and Prebiotic Food Consumption Form, and Finnish Type 2 Diabetes Risk Questionnaire via online survey. General adults were included in this study. Univariate analysis, logistic and multiple linear regression analyses were conducted.
Results: Of 401 adults, 51.6% were male and 78.80% were under 45 years of age. 89% of the sample stated they consumed prebiotic-probiotics. Logistic regression analysis showed that prebiotic-probiotic consumption was not a significant predictor of low (p = 0.127), mild (p = 0.381), moderate (p = 0.819), high (p = 0.588) and very high risk of type 2 diabetes (p = 0.998). In the research, linear regression research revealed that there was no meaningful connection between prebiotic-probiotic consumption status and type 2 diabetes risk (β = -0.072; p = 0.151).
Conclusion: This research shown that using probiotics or prebiotics did not increase the risk of type 2 diabetes. Thus, more research is required to determine the relation between the usege of probiotics or prebiotics and the risk of type 2 diabetes.

Anahtar Kelimeler

Adult, diabetes mellitus, prebiotics, probiotics, type 2

Etik Beyan

This study was conducted according to the Declaration of Helsinki. The ethical approval was obtained from the Burdur Mehmet Akif Ersoy University's Clinical Research Ethics Committee (Date: 03.11.2021 number: GO 2021/373). The participants were given information about the aim and procedure of the study on the first page of the online survey before starting the study. The data of the participants was kept private in accordance with Google's privacy policies. Informed consent was obtained from all participants via the first page of the online survey.

Yetişkin Popülasyonda Prebiyotik veya Probiyotik Tüketimi ile Tip 2 Diyabetes Mellitus Riski Arasındaki İlişki

Öz

Giriş: Mikrobiyota çeşitliliğindeki azalma, zararlı metabolitleri artırarak ve insülin direnci yolaklarını aktive ederek diyabet riskini artırmaktadır. Bu nedenle, yeterli prebiyotik ve probiyotik gıda tüketiminin tip 2 diyabetin önlenmesi için potansiyel bir araç olabileceği düşünülmektedir.
Amaç: Bu çalışmanın amacı prebiyotik ve probiyotik tüketimi ile tip 2 diyabet riski arasındaki ilişkiyi araştırmaktır.
Yöntem: Bu çalışmada kesitsel araştırma deseni kullanılmıştır. Veriler Aralık 2021 ve Haziran 2022 tarihleri arasında Kişisel Bilgi Formu, Probiyotik ve Prebiyotik Gıda Tüketiminin Değerlendirilmesi Formu ve Finlandiya Tip 2 Diyabet Risk Anketi kullanılarak çevrimiçi bir anket aracılığıyla toplanmıştır. Sağlıklı yetişkinler bu çalışmaya dahil edilmiştir. Tek değişkenli analiz, lojistik ve çoklu doğrusal regresyon analizleri kullanılmıştır.
Bulgular: Araştırmaya katılan 401 yetişkinin 51,6%’sı erkek olup, 78,80%’i 45 yaşın altındadır. Örneklemin 89,5%’si prebiyotik ve probiyotik tükettiğini ifade etmiştir. Lojistik regresyon analizi prebiyotik-probiyotik tüketiminin düşük (p = 0,127), hafif (p = 0,381), orta (p = 0,819), yüksek (p = 0,588) ve çok yüksek tip 2 diyabet riskinin (p = 0,998) anlamlı bir belirleyicisi olmadığını göstermiştir. Çalışmada doğrusal regresyon analizi prebiyotik-probiyotik tüketme durumu ile tip 2 diyabet riski arasında anlamlı bir ilişki olmadığını göstermiştir (β = -0,072; p = 0,151).
Sonuç: Bu çalışma, prebiyotik veya probiyotik tüketiminin tip 2 diyabet riski ile ilişkili olmadığını göstermiştir. Bu nedenle, prebiyotik veya probiyotik tüketimi ve tip 2 diyabet riskini inceleyen daha çok araştırmanın literatüre kazandırılmasına ihtiyaç bulunmaktadır.

Anahtar Kelimeler

Diabetes Mellitus, prebiyotikler, probiyotikler, tip 2, yetişkin

Kaynakça

• Ahmad, A., Yang, W., Chen, G., Shafiq, M., Javed, S., Ali Zaidi, S. S., Shahid R, … & Bokhari H. (2019). Analysis of gut microbiota of obese individuals with type2 diabetes and healthy individuals. PLoSone, 14(12), 1-15. doi: 10.1371/journal.pone.0226372
• Ardeshirlarijani, E., Tabatabaei-Malazy, O., Mohseni, S., Qorbani, M., Larijani, B., & Jalili, R.B. (2019). Effect of probiotics supplementation on glucose and oxidative stress in type 2 diabetes mellitus: A meta-analysis of randomized trials. DARU Journal of Pharmaceutical Sciences, 27(2), 827-837. doi: 10.1007/ s40199-019-00302-2
• Barengolts, E., Smith, E. D., Reutrakul, S., Tonucci, L., & Anothaisintawee, T. (2019). The effect of probiotic yogurt on glycemic control in type 2 diabetes or obesity: A meta-analysis of nine randomized controlled trials.Nutrients, 11(3), 1-18. doi: 10.3390/nu11030671
• Bock, P. M., Telo, G. H., Ramalho, R., Sbaraini, M., Leivas, G., Martins, A. F., & Schaan, B. D. (2021). The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: A systematic review meta-analysis. Diabetologia, 64(1), 26-41. doi: 10.1007/s00125-020-05295-1
• Borgeraas, H., Johnson, L. K., Skattebu, J., Hertel, J. K., & Hjelmesaeth, J. (2018). Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: A systematic review and meta-analysis of randomized controlled trials. Obesity Reviews, 19(2), 219-232. doi: 10.1111/obr.12626
• Chaudhari, A., Dwivedi, M. K. (2022). The concept of probiotics, prebiotics, postbiotics, synbiotics, nutribiotics, and pharmabiotics. In M. K Dwivedi, N. Amaresan, A. Sankaranarayanan & Kemp, E. H. (Eds.), Probiotics in the prevention and management of human diseases (pp. 1-11). Elsevier, Academic Press.
• Cerdó, T., García-Santos, J. A., Bermúdez M. G., & Campoy, C. (2019). The role of probiotics and prebiotics in the prevention and treatment of obesity. Nutrients, 11(3), 1-22. doi: 10.3390/nu11030635
• Chen, Z., Radjabzadeh, D., Chen, L., Kurilshikov, A., Kavousi, M., Ahmadizar, F., … & Voortman, T. (2021). Association of insulin resistance and type 2 diabetes with gut microbial diversity: A microbiome-wide analysis from population studies. Diabetes and Endocrinology, 4(7), 1-13. doi: 10.1001/ jamanetworkopen.2021.18811
• Colantonio, A. G., Werner, S. L., & Brown, M. (2020). The effects of prebiotics and substances with prebiotic properties on metabolic and inflammatory biomarkers in individuals with type 2 diabetes mellitus: A systematic review. Journal of the Academy of Nutrition and Dietetics, 120(4), 587-607. doi: 10.1016/j.jand.2018.12.013
• Corb Aron, R. A., Tit, D. M., Purza, A. L., Abid, A., Vesa, C. M., Angelescu, G., & Bungau S. G. (2021). Effects of probiotic supplementation on metabolic syndrome components in type 2 diabetes mellitus patients – A case-control study. Archives of the Balkan Medical Union, 56(2), 201-212. doi: 10.31688/ ABMU.2021.56.2.09
• Dean, A. G. (1996). Epi info, version 6: A word-processing, database, and statistics program for public health on ibm-compatible microcomputers. Atlanta, Georgia: Centers for Disease Control and Prevention.
• Türkiye Endokrinoloji ve Metabolizma Derneği (2022). TEMD diabetes mellitus ve komplikasyonlarınin tanı, tedavi ve izlem kılavuzu. Retrieved date: November 06, 2023. Retrived from: diabetes-mellitus_2022.pdf (temd.org.tr).
• Ding, L. N., Ding, W. Y., Ning, J., Wang, Y., Yan, Y., & Wang, Z. B. (2021) Effects of probiotic supplementation on inflammatory markers and glucose homeostasis in adults with type 2 diabetes mellitus: A systematic review and meta-analysis. Frontiers in Pharmacology 12:(770861), 1-16. doi: 10.3389/fphar.2021.770861
• Dong, Y., Xu, M., Chen, L., & Bhochhibhoya, A. (2019). Probiotic foods and supplements interventions for metabolic syndromes: A Systematic review and meta-analysis of recent clinical trials. Annals of Nutrition & Metabolism, 74(3), 224-241. doi: 10.1159/000499028
• Jiang, H., Cai, M., Shen, B., Wang, Q., Zhang, T., & Zhou, X. (2022). Synbiotics and Gut microbiota: new perspectives in the treatment of type 2 diabetes mellitus. Foods, 11(16), 1-18. doi: https://doi.org/10.3390/foods11162438
• Kamarlı Altun, E., & Akar Yıldız, E. (2017). Relationship between prebiotics-probiotics and diabetes mellitus. Turkish Journal of Life Science, 2(1), 149-156.
• Kassaian, N., Feizi, A, Aminorroaya, A, Ebrahimi, M. T., Norouzi, A., & Amini, M. (2019). Effects of probiotics and synbiotic on lipid profiles in adults at risk of type 2 diabetes: A double-blind randomized controlled clinical trial. Functional Foods in Health and Disease, 9(7), 494-507. doi: 10.31989/ffhd.v9i7.617
• Kaya Cebioğlu, İ., & Önal, A. E. (2019). Investigation the relation between the consumption of probiotic and prebiotic foods and obesity among adults, living in a district in İstanbul. Journal of Traditional and Complementary Medicine, 2(2), 55-63. doi: 10.5336/jtracom.2019-65731
• Kellow, N. J., Coughlan, M. T., & Reid, C. M. (2014). Metabolic benefits of dietary prebiotics in human subjects: A systematic review of randomised controlled trials. British Journal of Nutrition, 111(7), 1147-1161. doi: 10.1017/S0007114513003607
• Khalil, N. A., Eltahan, N. R., Elaktash H. M., Aly, S., & Razid Sarbini S. (2021). Prospective evaluation of probiotic and prebiotic supplementation on diabetic health associated with gut microbiota. Food Bioscience, 42(2), 1-8. doi: 10.1016/j.fbio.2021.101149
• Kim, Y. A., Keogh, J. B., & Clifton, P. M. (2018). Probiotics, prebiotics, synbiotics and insulin sensitivity. Nutrition Research Reviews, 31(1), 35-51. doi:10.1017/ S095442241700018X
• Köse, B., Aydın, A., Ozdemir, M., & Yeşil, E. (2019). Determination of the knowledge level and consumption of probiotic, prebiotic and sinbioticals on healthcare prosfesional. Academic Journal of Gastroenterology, 18(2), 67-72. doi: 10.38079/igusabder.784094
• Lee, C. J., Sears, C. L., & Maruthur, N. (2019). Gut microbiome and its role in obesity and insulin resistance. Annals of the New York Academy and Science, 1461(1), 37-52. doi: 10.1111/nyas.14107
• Lindström, J., & Tuomilehto, J. (2003). The diabetes risk score: A practical tool to predict type 2 diabetes risk. Diabetes Care, 26(3), 725-731. doi: 10.2337/ diacare.26.3.725
• Mahboobi, S., Rahimi, F., & Jafarnejad, S. (2018). Effects of prebiotic and synbiotic supplementation on glycaemia and lipid profile in type 2 diabetes: A meta-analysis of randomized controlled trials. Advanced Pharmaceutical Bulletin, 8(4), 565-574. doi: 10.15171/apb.2018.065
• Miraghajani, M., Dehsoukhteh, S. S., Rafie N., Hamedani, S. G., Sabihi, S., & Ghiasvand, R. (2017). Potential mechanisms linking probiotics to diabetes: A narrative review of the literature. Sao Paulo Medical Journal, 135(2), 169-178. doi: 10.1590/1516-3180.2016.0311271216
• Ojo, O., Wang, X., Ojo, Osaretin Ojo, O., Brooke, J., Yiqing, J., Dong, Q., & Thompson, T. (2022). The effect of prebiotics and oral anti-diabetic agents on gut microbiome in patients with type 2 diabetes: A systematic review and network meta-analysis of randomised controlled trials. Nutrients, 14(23), 5139. doi: 10.3390/nu14235139
• Ong, K. L., Stafford, L. K., McLaughlin, S. A., Boyko, E. J., Vollset, S. E., Smith, A. E., … & Vos, T. (2023). Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the global burden of disease study 2021. The Lancet, 402(10397), 203-234. doi:10.1016/S0140-6736(23)01301-6
• Paul, P., Kaul, R., Harfouche, M., Arabi, M., Al-Najjar, Y., Sarkar, A., … & Chaari, A. (2022). The effect of microbiome-modulating probiotics, prebiotics and synbiotics on glucose homeostasis in type 2 diabetes: A systematic review, meta-analysis, and meta-regression of clinical trials. Pharmacological Research, 185(106520), 1-22. doi: 10.1016/j.phrs.2022.106520
• Patterson, E., Ryan, P. M., Cryan, J. F., Dinan, T. G., Ross, R. P., Fitzgerald, G. F., & Stanton, C. (2016). Gut microbiota, obesity and diabetes. Postgraduate Medical Journal, 92(1087), 286-300. doi: 10.1136/postgradmedj-2015-133285.
• Quigley, E. M. (2019). Prebiotics and probiotics in digestive health. Clinical Gastroenterology and Hepatology, 17(2), 333-344. doi: 10.1016/j.cgh.2018.09.028
• Rabiei, S., Hedayati, M., Rashidkhani, B., Saadat, N., & Shakerhossini, R. (2019). The effects of synbiotic supplementation on body mass index, metabolic and inflammatory biomarkers, and appetite in patients with metabolic syndrome: A triple-blind randomized controlled trial. Journal of Dietary Supplements, 16(3), 294-306. doi: 10.1080/19390211.2018.1455788
• Raygan, F., Rezavandi, Z., Bahmani, F., Ostadmohammadi, V., Mansournia M. A., TajabadiEbrahimi, M., … & Asemi, Z. (2018). The effects of probiotic supplementation on metabolic status in type 2 diabetic patients with coronary heart disease. Diabetology & Metabolic Syndrome, 10(51), 1-7. doi: 10.1186/ s13098-018-0353-
• Razmpoosh, E., Javadi, A., Ejtahed, H. S., Mirmiran, P., Javadi, M., & Yousefinejad, A. (2019). The effect of probiotic supplementation on glycemic control and lipid profile in patients with type 2 diabetes: A randomized placebo controlled trial. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(1), 175-182. doi: 10.1016/j.dsx.2018.08.008
• Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M.C. (2019). What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms, 7(1), 1-22. doi: 10.3390/microorganisms7010014
• Ruan, Y., Sun J., He J., Chen F., Chen, R., & Chen, H. (2015). Effect of probiotics on glycemic control: A systematic review and meta-analysis of randomized, controlled trials. PLoS One, 10(7), 1-15. doi: 10.1371/journal.pone.0132121
• Sezer, Ö., Özdoğan Lafçi, N., Korkmaz, S., & Dağdeviren, H. N. (2021). Prediction of a 10-year risk of type 2 diabetes mellitus in the turkish population: A cross-sectional study. Medicine (Baltimore), 100(44), 1-6. doi: 10.1097/ md.0000000000027721
• Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., … & Magliano, D. J. (2022). IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice, 183, 109119. doi: 10.1016/j.diabres.2021.109119
• Sun, J., and Buys, N. (2015). Effects of probiotics consumption on lowering lipids and CVD risk factors: A systematic review and meta-analysis of randomized controlled trials. Annals of Medicine, 47, 430-440. doi: 10.3109/07853890.2015.
• T.C. Ministry of Health, General Directorate of Public Health, Türkiye Nutrition and Health Research, 2019. Retrived date: 05.10.2021. Retrived from: chrome extension://efaidnbmnnnibpcajpcglclefindmkaj/https://krtknadmn.karatekin. edu.tr/files/sbf/TBSA_RAPOR_KITAP_20.08.pdf
• Umirah, F., Neoh, C. F., Ramasamy, K., & Siong Meng Lim, S. M. (2021). Differential gut microbiota composition between type 2 diabetes mellitus patients and healthy controls: A systematic review. Diabetes Research and Clinical Practice, 173(108689): doi: 10.1016/j.diabres.2021.108689.
• Venema, K., & Do Carmo, A. P. (2015). Probiotics and prebiotics current research and future trends. Norfolk, UK: Caister Academic Press.
• Von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2014). The strengthening the reporting of observational studies in epidemiology (strobe) statement: Guidelines for reporting observational studies. International Journal of Surgery, 12(12), 1495-1499. doi: 10.1016/j.ijsu.2014.07.013
• Wang, X., Yang, J., Qiu, X., Wen, Q., Liu, M., Zhou, D., & Chen, Q. (2021). Probiotics, pre-biotics and synbiotics in the treatment of pre-diabetes: A systematic review of randomized controlled trials. Frontiers in Public Health, 26(9), 2-10. doi: 10.3389/fpubh.2021.645035
• Wiciński, M., Gębalski, J., Gołębiewski, J., & Malinowski, B. (2020). Probiotics for the treatment of overweight and obesity in humans-a review of clinical trials. Microorganisms, 8(8), 1-19. doi: 10.3390/microorganisms8081148
• Włodarczyk, M., & Slizewska, K. (2021). Obesity as the 21st Century’s major disease: The role of probiotics and prebiotics in prevention and treatment. Food Bioscience, 42(101115), 1-24. doi: 10.1016/j.fbio.2021.101115.
• Wu, H., Tremaroli, V., Schmidt, C., Lundqvist, A., Olsson, L. M., Krämer, M., ... & Bäckhed, F. (2020). The gut microbiota in prediabetes and diabetes: A population-based cross-sectional study. Cell metabolism, 32(3), 379-390. doi: 10.1016/j.cmet.2020.06.011
• Zeratsky, K. (2022). What are probiotics and prebiotics? Retrieved date: 06.11.2023. Retrieved from: https://www.mayoclinic.org/healthy-lifestyle/ nutrition-and-healthy-eating/expertanswers/probiotics/faq20058065#:~:- text=Probiotics%20are%20in%20foods%20such,%2C%20garlic%2C%20 soybeans%20and%20artichokes.
• Zhang, Q., Wu, Y., & Fei, X. (2015). Effect of probiotics on body weight and bodymass index: a systematic review and meta-analysis of randomized, controlled trials. International Journal of Food Science and Nutrition, 67(5), 571-80. doi: m10.1080/09637486.2016.1181156